¼¼°èÀÇ °ñ¹ÝÀú Áø´Ü ½ÃÀå
Pelvic Floor Diagnostics
»óǰÄÚµå : 1577482
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 299 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,372,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,117,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

°ñ¹ÝÀú Áø´Ü ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 6¾ï 4,460¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â 4¾ï 9,190¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â °ñ¹ÝÀú Áø´Ü ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 6¾ï 4,460¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â µ¿¾È ¿¬Æò±Õ 3.9% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÃÊÀ½ÆÄ ½Ã½ºÅÛÀº CAGR 5.0%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 1¾ï 8,310¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, Uroflowmetry Systems ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 1¾ï 3,400¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.5%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ °ñ¹ÝÀú Áø´Ü ½ÃÀåÀº 2023³â 1¾ï 3,400¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2023-2030³â 7.5%ÀÇ CAGR·Î 2030³â±îÁö 1¾ï 3,750¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ºÐ¼® ±â°£ µ¿¾È °¢°¢ 1.3%¿Í 3.0%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ 2.1%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è °ñ¹ÝÀú Áø´Ü ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

°ñ¹ÝÀú Áø´ÜÀÌ ¿©¼º °Ç°­°ü¸®¿¡¼­ ÁÖ¸ñ¹Þ´Â ÀÌÀ¯´Â?

°ñ¹ÝÀú Áø´ÜÀº °ñ¹ÝÀú Àå¾Ö(PFD)¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ¿©¼ºÀÇ »îÀÇ Áú¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡±â ¶§¹®¿¡ ¿©¼º °Ç°­ °ü¸®¿¡¼­ ºü¸£°Ô ÁÖ¸ñÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ±×·¸´Ù¸é ¿Ö °ñ¹ÝÀú ÁúȯÀÇ Áø´ÜÀÌ Áß¿äÇÑ °ÍÀϱî? ±×¸®°í °ñ¹ÝÀú Áø´ÜÀÌ Àü¹® ºÐ¾ß·Î ÁÖ¸ñ¹Þ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî? ¿ä½Ç±Ý, °ñ¹ÝÀå±âÅ»ÃâÁõ, º¯½Ç±Ý µîÀÇ ÁúȯÀº ƯÈ÷ Ãâ»ê, Æó°æ, ºñ¸¸ µîÀ» °æÇèÇÑ ¿©¼º¿¡°Ô ¸¹ÀÌ ¹ß»ýÇÔ¿¡µµ ºÒ±¸Çϰí Áø´Ü°ú Ä¡·á°¡ Á¦´ë·Î ÀÌ·ç¾îÁöÁö ¾Ê´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ Àå¾Ö¸¦ ¹æÄ¡ÇÏ¸é ¸¸¼º ÅëÁõ, ¼º±â´É Àå¾Ö, Á¤½ÅÀû °íÅë µî ½ÅüÀû, ½É¸®Àû ÇÕº´ÁõÀÇ ¿¬¼â¸¦ À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. È¿°úÀûÀÎ °ñ¹ÝÀú Áø´Ü¿¡´Â °ñ¹ÝÀú±ÙÀ°°ú °ü·Ã ±¸Á¶¹°ÀÇ ±â´É, °­µµ, ÇùÀÀ·ÂÀ» Æò°¡Çϱâ À§ÇØ °í¾ÈµÈ ´Ù¾çÇÑ Àü¹® °Ë»ç ¹× ¿µ»ó ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. °ñ¹Ý ÃÊÀ½ÆÄ °Ë»ç, ¿ªµ¿Àû MRI, °ñ¹ÝÀú±ÙÀüµµ °Ë»ç, °ñ¹ÝÀú±ÙÀüµµ °Ë»ç µî ´Ù¾çÇÑ Ä¡·á¹ýÀ» ÅëÇØ º´Å»ý¸®¸¦ ÀÚ¼¼È÷ ÀÌÇØÇϰí ÀÓ»óÀǰ¡ ¸ÂÃãÇü Ä¡·á °èȹÀ» ¼ö¸³ÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¾ÇÕÀûÀÎ ¿©¼º °Ç°­ ¼­ºñ½º¿¡ ´ëÇÑ Àνİú ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °ñ¹ÝÀú Áø´ÜÀº ÀÏ»ó Áø·áÀÇ ÇʼöÀûÀÎ ºÎºÐÀÌ µÇ¾î ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇϰí, Ä¡·á °á°ú¸¦ ÃÖÀûÈ­Çϸç, ±Ã±ØÀûÀ¸·Î ȯÀÚÀÇ À£ºùÀ» Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â °ñ¹Ý °Ç°­°ú Àü¹ÝÀûÀÎ »îÀÇ Áú »çÀÌÀÇ º¹ÀâÇÑ »óÈ£°ü°è¸¦ ÀνÄÇÏ°í ¿©¼º °Ç°­¿¡ ´ëÇÑ º¸´Ù ÃÑüÀûÀ̰í Àû±ØÀûÀÎ Á¢±Ù ¹æ½ÄÀ¸·ÎÀÇ ÀüȯÀ» º¸¿©ÁÝ´Ï´Ù.

°ñ¹ÝÀú Áø´ÜÀÇ ¹Ì·¡¸¦ Á¿ìÇÒ »õ·Î¿î Æ®·»µå´Â ¹«¾ùÀΰ¡?

°ñ¹ÝÀú Áø´Ü ½ÃÀåÀº ȯÀÚ ÀνÄÀÇ Çâ»ó, ±â¼ú ¹ßÀü, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀ¸·Î ÀÎÇØ ºü¸£°Ô ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­Çϸ鼭 °ñ¹Ý ±¸Á¶¸¦ »ó¼¼ÇÏ°Ô º¼ ¼ö ÀÖ´Â ºñħ½ÀÀû Áø´Ü ±â¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. 3D/4D ÃÊÀ½ÆÄ³ª ´ÙÀ̳ª¹Í MRI¿Í °°Àº °íÇØ»óµµ ¿µ»ó ±â¼úÀº °ñ¹ÝÀúÀÇ ¿òÁ÷ÀÓ°ú ±â´ÉÀ» ½Ç½Ã°£À¸·Î Æ÷ÂøÇÒ ¼ö Àֱ⠶§¹®¿¡ °ñ¹Ý Àå±â Å»ÃâÁõÀ̳ª ±ÙÀ§ÃàÁõ°ú °°Àº ÁúȯÀ» º¸´Ù Á¤È®ÇÏ°Ô Áø´ÜÇÒ ¼ö ÀÖ½À´Ï´Ù. °ñ¹ÝÀå±âÅ»ÃâÁõ, ±ÙÀ§ÃàÁõ°ú °°Àº ÁúȯÀ» º¸´Ù Á¤È®ÇÏ°Ô Áø´ÜÇÒ ¼ö ÀÖ°Ô µÇ¾î ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ »õ·Î¿î Æ®·»µå´Â ¿ø°Ý ¸ð´ÏÅ͸µ°ú ȯÀÚÀÇ ÀÚ°¡ °ü¸®¸¦ Áö¿øÇϱâ À§ÇÑ µðÁöÅÐ Çコ ±â¼úÀÇ È°¿ëÀÔ´Ï´Ù. ¹ÙÀÌ¿ÀÇǵå¹é°ú ¸ð¹ÙÀÏ ¾Û ¿¬°á ±â´ÉÀ» °®Ãá ¿þ¾î·¯ºí °ñ¹Ý °Ç°­ ±â±â´Â ȯÀÚ°¡ Áý¿¡¼­ °æ°ú¸¦ ÃßÀûÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© °ñ¹ÝÀú Ä¡·áÀÇ ¼øÀÀµµ¸¦ ³ôÀ̰í, ÀæÀº º´¿ø ¹æ¹® ¾øÀ̵µ Áö¼ÓÀûÀÎ Æò°¡°¡ °¡´ÉÇϵµ·Ï ÇÕ´Ï´Ù. ¶ÇÇÑ ÀþÀº ¿©¼º, ƯÈ÷ Ãâ»ê ÈÄ ÇÕº´ÁõÀ» ¿¹¹æÇÏ·Á´Â ¿©¼ºµé »çÀÌ¿¡¼­ °ñ¹ÝÀú °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¿¹¹æ Áø´Ü ¹× Á¶±â °³ÀÔ Àü·«ÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °ñ¹ÝÀú Àü¹® Ŭ¸®´ÐÀÇ ¼³¸³ÀÌ ´«¿¡ ¶ç°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, ´ÙÇÐÁ¦ ÆÀÀÌ ÇÑ ÁöºØ ¾Æ·¡¿¡¼­ Á¾ÇÕÀûÀÎ Áø´Ü ¹× Ä¡·á ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¾çÁúÀÇ Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó °ñ¹Ý °Ç°­ °ü¸®¸¦ À§ÇÑ º¸´Ù Á¾ÇÕÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ´õ ¸¹Àº ¿©¼ºµéÀÌ °ñ¹Ý °Ç°­¿¡ ´ëÇØ ´õ Àû±ØÀûÀ¸·Î °ü½ÉÀ» °®°í Á¶±â °ËÁøÀ» ¹ÞÀ¸·Á´Â °æÇâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ Ãß¼¼´Â º¸´Ù ȯÀÚ Áß½ÉÀûÀ̰í, Á¢±Ù¼ºÀÌ ³ôÀ¸¸ç, ±â¼úÀûÀ¸·Îµµ Áøº¸µÈ ¹æ½ÄÀ¸·Î º¯È­Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº °ñ¹ÝÀú Áø´ÜÀÇ °üÇàÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

±â¼ú Çõ½ÅÀº °ñ¹ÝÀú Áø´Ü¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ º¸´Ù Á¤È®Çϰí, ȯÀÚ Ä£È­ÀûÀ̸ç, È¿°úÀûÀÎ Áø´ÜÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. °¡Àå ¿µÇâ·Â ÀÖ´Â ¹ßÀü Áß Çϳª´Â °ñ¹ÝÀúÀÇ ±¸Á¶¿Í ±â´É¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ´Â µ¿Àû MRI ¹× 3D/4D ÃÊÀ½ÆÄ µî °íÇØ»óµµ ¿µ»ó ±â¼úÀÇ ÅëÇÕÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀ» ÅëÇØ ÀÓ»óÀÇ´Â ±âÁ¸ ¹æ¹ýÀ¸·Î´Â ³õÄ¡±â ½¬¿î ¹Ì¹¦ÇÑ ÇØºÎÇÐÀû º¯È­¿Í ±â´É Àå¾Ö¸¦ ¹ß°ßÇÒ ¼ö ÀÖ¾î º¸´Ù ºü¸£°í Á¤È®ÇÑ Áø´ÜÀ» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ¿µ»ó Áø´Ü ¿Ü¿¡µµ ÃֽŠ¿ä·Î¿ªÇÐ ½Ã½ºÅÛÀº ¹æ±¤°ú ¿äµµÀÇ ±â´ÉÀ» Á¤È®ÇÏ°Ô ÃøÁ¤ÇÏ´Â ¼ÒÇÁÆ®¿þ¾î¸¦ °­È­ÇÏ¿© ¿ä½Ç±Ý ¹× ±âŸ ¹è´¢ Àå¾ÖÀÇ ±Ùº» ¿øÀÎÀ» ÆÄ¾ÇÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â µî ´õ¿í Á¤±³ÇØÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹ÙÀÌ¿ÀÇǵå¹é ¼¾¼­°¡ ÀåÂøµÈ ¿þ¾î·¯ºí ±â±â´Â °ñ¹Ý ±ÙÀ° Ȱµ¿À» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°ÔÇÔÀ¸·Î½á ȯÀÚ¿ÍÀÇ °ü°è¸¦ º¯È­½Ã۰í ÀÖ½À´Ï´Ù. Áý¿¡¼­ °ñ¹ÝÀú±Ù ¿îµ¿À» ÇÒ ¶§ »ç¿ëÇÒ ¼ö ÀÖ´Â ÀÌ ±â±âµéÀº ȯÀÚ¿¡°Ô Áï°¢ÀûÀÎ Çǵå¹éÀ» Á¦°øÇÏ¿© ¿Ã¹Ù¸¥ ±â¼úÀ» º¸ÀåÇϰí Ä¡·á °á°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. µðÁöÅÐ °Ç°­ Ç÷§ÆûÀº ¶ÇÇÑ ¿ø°ÝÁø·á¸¦ ¿ëÀÌÇϰÔÇϰí ÀÓ»óÀǰ¡ ȯÀÚÀÇ °æ°ú¸¦ Àå±âÀûÀ¸·Î ÃßÀû ÇÒ ¼ö ÀÖµµ·ÏÇÔÀ¸·Î½á Áß¿äÇÑ ¿ªÇÒÀ»Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áø´Ü µµ±¸¿¡ ÀΰøÁö´É(AI)À» ÅëÇÕÇÏ¿© º¹ÀâÇÑ µ¥ÀÌÅÍ ¼¼Æ®ÀÇ ÇØ¼®¿¡ »õ·Î¿î ¼öÁØÀÇ Á¤È®¼ºÀ» Á¦°øÇÏ¿© ÀÓ»óÀǰ¡ ÆÐÅÏÀ» ÀνÄÇÏ°í ´õ ¸¹Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº °ñ¹ÝÀú Áø´ÜÀÇ È¿°ú¿Í Á¤È®¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, °ñ¹Ý °Ç°­ °ü¸®¿¡ ´ëÇÑ º¸´Ù °³ÀÎÈ­µÈ ȯÀÚ Áß½ÉÀÇ Á¢±Ù ¹æ½ÄÀ» À§ÇÑ ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù.

°ñ¹ÝÀú Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

°ñ¹ÝÀú Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀº °ñ¹ÝÀú Àå¾ÖÀÇ À¯º´·ü Áõ°¡, ¿©¼º °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Áø´Ü ±â¼úÀÇ ¹ßÀü µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â Àα¸ÀÇ °í·ÉÈ­À̸ç, °í·É ¿©¼ºÀº ±ÙÀ°°ú °áÇÕ Á¶Á÷ÀÇ ÀÚ¿¬ÀûÀÎ ¾àÈ­·Î ÀÎÇØ °ñ¹ÝÀú ±â´É Àå¾Ö¸¦ °æÇèÇÒ °¡´É¼ºÀÌ ´õ ³ô½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸Åë°èÇÐÀû º¯È­·Î ÀÎÇØ °ñ¹ÝÀå±âÅ»ÃâÁõ ¹× ¿ä½Ç±Ý°ú °°Àº ÁúȯÀ» ½Äº°ÇÏ°í °ü¸®Çϱâ À§ÇÑ Áø´Ü Æò°¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀº °ñ¹Ý °Ç°­ÀÌ Àü¹ÝÀûÀÎ »îÀÇ Áú¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Á¶±â °ËÁø ¹× Àû±ØÀûÀÎ °ü¸® Àü·«ÀÌ ±ÞÁõÇϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â Àå±âÀûÀÎ ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇØ ½É°¢ÇÑ Áõ»óÀÌ ¾ø¾îµµ Àü¹®ÀûÀÎ Áø´ÜÀ» ¹ÞÀ¸·Á´Â ¿©¼ºµéÀÇ Áõ°¡¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñħ½ÀÀû ¹× ÃÖ¼Òħ½ÀÀû Áø´Ü ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ °ñ¹ÝÀú Æò°¡°¡ ȯÀڵ鿡°Ô ´õ Æí¾ÈÇÏ°í ´ú À§ÇùÀûÀ¸·Î ´À²¸Áú ¼ö ÀÖµµ·Ï ¼±ÅÃÀÇ ÆøÀÌ ³Ð¾îÁö°í ÀÖ½À´Ï´Ù. °íÇØ»óµµ ¿µ»ó Áø´Ü°ú ÷´Ü °ñ¹Ýµ¿ °Ë»ç·Î Áø´ÜÀÇ Á¤È®µµ°¡ Çâ»óµÇ°í Ä¡·á °èȹ°ú Ä¡·á °á°ú°¡ °³¼±µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °ñ¹Ý Àü¹® Ŭ¸®´Ð°ú ¼­ºñ½ºÀÇ È®´ë·Î Àü¹® Áø·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖÀ¸¸ç, ƯÈ÷ ÀÚ¿øÀÌ Á¦ÇÑÀûÀ̾ú´ø Áö¿ª¿¡¼­µµ Àü¹® Áø·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ¾Û°ú ¿þ¾î·¯ºí ±â±â µî µðÁöÅÐ Çコ ÅøÀÇ ÅëÇÕÀº ¿ø°Ý ¸ð´ÏÅ͸µ°ú Áö¼ÓÀûÀΠȯÀÚ Âü¿©¸¦ °¡´ÉÇϰÔÇÔÀ¸·Î½á ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ¿©¼ºÀÇ °Ç°­°ú º¹Áö Çâ»ó¿¡ ´ëÇÑ »çȸÀû °ü½É Áõ°¡¿Í ÇÔ²² °ñ¹ÝÀú Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, ÇコÄÉ¾î »ê¾÷¿¡¼­ ¼ºÀå°ú Çõ½ÅÀÇ ÇÙ½É ºÐ¾ß·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 53°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Pelvic Floor Diagnostics Market to Reach US$644.6 Million by 2030

The global market for Pelvic Floor Diagnostics estimated at US$491.9 Million in the year 2023, is expected to reach US$644.6 Million by 2030, growing at a CAGR of 3.9% over the analysis period 2023-2030. Ultrasound Systems, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$183.1 Million by the end of the analysis period. Growth in the Uroflowmetry Systems segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$134.0 Million While China is Forecast to Grow at 7.5% CAGR

The Pelvic Floor Diagnostics market in the U.S. is estimated at US$134.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$137.5 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Pelvic Floor Diagnostics Market - Key Trends and Drivers Summarized

Why Is Pelvic Floor Diagnostics Becoming a Key Focus in Women’s Healthcare?

Pelvic floor diagnostics is rapidly gaining traction in women’s healthcare, driven by the increasing recognition of pelvic floor disorders (PFDs) and their substantial impact on women’s quality of life. But why is diagnosing these conditions so crucial, and what makes pelvic floor diagnostics a specialized area of focus? Conditions such as urinary incontinence, pelvic organ prolapse, and fecal incontinence are often underdiagnosed and undertreated, despite being highly prevalent among women, especially those who have experienced childbirth, menopause, or obesity. These disorders can lead to a cascade of physical and psychological complications, including chronic pain, sexual dysfunction, and emotional distress, if left untreated. Effective pelvic floor diagnostics involve a range of specialized tests and imaging techniques designed to evaluate the function, strength, and coordination of the pelvic floor muscles and related structures. Methods such as pelvic ultrasound, dynamic MRI, and urodynamic studies provide a detailed understanding of the condition, enabling clinicians to develop targeted, individualized treatment plans. With growing awareness and demand for comprehensive women’s health services, pelvic floor diagnostics are becoming an integral part of routine care, helping to identify issues early, optimize treatment outcomes, and ultimately enhance patient well-being. This trend marks a shift towards a more holistic and proactive approach in women’s health, recognizing the complex interplay between pelvic health and overall quality of life.

What Are the Emerging Trends Shaping the Future of Pelvic Floor Diagnostics?

The pelvic floor diagnostics market is evolving rapidly, driven by a combination of increased patient awareness, technological advancements, and a broader emphasis on personalized healthcare. One of the most significant trends is the rising adoption of non-invasive diagnostic technologies, which provide detailed visualizations of pelvic structures with minimal discomfort. High-resolution imaging techniques, such as 3D/4D ultrasound and dynamic MRI, are becoming preferred options due to their ability to capture real-time movement and function of the pelvic floor, allowing for more precise diagnosis of conditions like pelvic organ prolapse and muscle dysfunction. Another emerging trend is the use of digital health technologies to support remote monitoring and patient self-management. Wearable pelvic health devices, equipped with biofeedback and mobile app connectivity, enable patients to track their progress at home, enhancing adherence to pelvic floor therapy and allowing for continuous assessment without frequent clinical visits. Additionally, the growing focus on pelvic floor health among younger women, particularly those seeking to prevent post-partum complications, is driving the adoption of preventative diagnostics and early intervention strategies. There is also a notable increase in the establishment of specialized pelvic floor clinics, where multi-disciplinary teams offer integrated diagnostic and therapeutic services under one roof. This trend is not only improving access to high-quality care but is also fostering a more comprehensive approach to managing pelvic health. With more women becoming proactive about their pelvic health and seeking early screening, these trends are reshaping the landscape of pelvic floor diagnostics, making it more patient-centered, accessible, and technologically advanced.

How Are Technological Advancements Transforming Pelvic Floor Diagnostic Practices?

Technological innovations are revolutionizing pelvic floor diagnostics, making the process more accurate, patient-friendly, and effective. One of the most impactful advancements is the integration of high-resolution imaging technologies, such as dynamic MRI and 3D/4D ultrasound, which provide detailed insights into pelvic floor structure and function. These technologies allow clinicians to detect subtle anatomical changes and dysfunctions that might be missed by conventional methods, leading to earlier and more accurate diagnoses. In addition to imaging, modern urodynamic systems have become more sophisticated, with enhanced software that offers precise measurements of bladder and urethral function, helping to identify the underlying causes of urinary incontinence and other voiding disorders. Furthermore, wearable devices equipped with biofeedback sensors are transforming patient engagement by allowing real-time monitoring of pelvic muscle activity. These devices, which can be used during home-based pelvic floor exercises, provide patients with immediate feedback, ensuring correct technique and improving therapeutic outcomes. Digital health platforms are also playing a critical role by facilitating remote consultations and enabling clinicians to track patient progress over time, thus making specialized pelvic health services more accessible. Moreover, the integration of artificial intelligence (AI) into diagnostic tools is providing new levels of precision in interpreting complex data sets, assisting clinicians in recognizing patterns and making more informed decisions. These technological innovations are not only enhancing the effectiveness and accuracy of pelvic floor diagnostics but are also paving the way for a more personalized and patient-driven approach to pelvic health management.

What Factors Are Fueling the Growth of the Pelvic Floor Diagnostics Market?

The growth of the pelvic floor diagnostics market is being driven by several key factors, including a rising prevalence of pelvic floor disorders, growing awareness of women’s health, and advances in diagnostic technology. One of the main growth drivers is the aging population, as older women are more likely to experience pelvic floor dysfunction due to the natural weakening of muscles and connective tissues. This demographic shift is significantly increasing the demand for diagnostic evaluations to identify and manage conditions such as pelvic organ prolapse and urinary incontinence. Another critical factor is the growing recognition of the impact of pelvic health on overall quality of life, leading to a surge in early screenings and proactive management strategies. This shift is encouraging more women to seek out specialized diagnostics, even in the absence of severe symptoms, to prevent long-term complications. Additionally, advancements in non-invasive and minimally invasive diagnostic techniques are expanding the range of available options, making pelvic floor assessments more comfortable and less intimidating for patients. The use of high-resolution imaging and sophisticated urodynamic testing is enhancing the accuracy of diagnoses, thereby improving treatment planning and outcomes. Furthermore, the expansion of dedicated pelvic health clinics and services is increasing access to specialized care, particularly in regions where such resources were previously limited. The integration of digital health tools, such as mobile apps and wearable devices, is also contributing to market growth by enabling remote monitoring and ongoing patient engagement. These factors, combined with a growing societal emphasis on improving women’s health and well-being, are driving the expansion of the pelvic floor diagnostics market, positioning it as a vital area of growth and innovation in the healthcare industry.

Select Competitors (Total 53 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â